Thursday - July 31, 2025
Only a Third of Eligible Patients Received Nirsevimab in First Season
July 17, 2025
ITASCA, Illinois, July 17 [Category: Medical] -- The American Academy of Pediatrics issued the following news release:

* * *

Only a Third of Eligible Patients Received Nirsevimab in First Season

*

Only one-third of eligible patients were given nirsevimab, a new antibody vaccination for respiratory syncytial virus (RSV), in its first season available during 2023-2024, according to a study from the Children's Hospital of Philadelphia. The st . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products